Exact Sciences receives regulatory approval for the Oncotype DX Breast Recurrence Score® Program in Japan
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX...
Source: prnewswire.com